RIVASTIGMINE
PRO DOC LIMITEE
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is RIVASTIGMINE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that RIVASTIGMINE 1.5MG has been permanently discontinued (last updated April 5, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is RIVASTIGMINE not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-RIVASTIGMINE
APOTEX INC
Other Products
EXELON
KNIGHT THERAPEUTICS INC.
PMS-RIVASTIGMINE
PHARMASCIENCE INC
RIVASTIGMINE TARTRATE CAPSULES
DR REDDY'S LABORATORIES LTD
MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
MYLAN-RIVASTIGMINE
MYLAN PHARMACEUTICALS ULC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02416999
Strength
1.5MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from PRO DOC LIMITEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
400MG · DIN 02164426
100MG · DIN 02164396
200MG · DIN 02164418
325MG · DIN 00382752
500MG · DIN 00386626
70MG · DIN 02303078
10MG · DIN 02414759
100MG · DIN 00555681
200MG · DIN 02130157
300MG · DIN 00555703
12.5MG · DIN 02424029
DIN 00870943